- Home
- AADI vs TTOO Comparison
AADI vs TTOO Comparison
Compare AADI & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AADI
- TTOO
- Stock Information
- Founded
- AADI 2011
- TTOO 2006
- Country
- AADI United States
- TTOO United States
- Employees
- AADI N/A
- TTOO N/A
- Industry
- AADI Biotechnology: Pharmaceutical Preparations
- TTOO Medical/Dental Instruments
- Sector
- AADI Health Care
- TTOO Health Care
- Exchange
- AADI Nasdaq
- TTOO Nasdaq
- Market Cap
- AADI 59.4M
- TTOO 10.7M
- IPO Year
- AADI N/A
- TTOO 2014
- Fundamental
- Price
- AADI $3.39
- TTOO $0.35
- Analyst Decision
- AADI Hold
- TTOO Hold
- Analyst Count
- AADI 3
- TTOO 1
- Target Price
- AADI $1.75
- TTOO $5.00
- AVG Volume (30 Days)
- AADI 615.0K
- TTOO 1.1M
- Earning Date
- AADI 11-06-2024
- TTOO 02-13-2025
- Dividend Yield
- AADI N/A
- TTOO N/A
- EPS Growth
- AADI N/A
- TTOO N/A
- EPS
- AADI N/A
- TTOO N/A
- Revenue
- AADI $25,070,000.00
- TTOO $7,677,000.00
- Revenue This Year
- AADI $9.39
- TTOO $50.31
- Revenue Next Year
- AADI $6.15
- TTOO $117.92
- P/E Ratio
- AADI N/A
- TTOO N/A
- Revenue Growth
- AADI 7.80
- TTOO N/A
- 52 Week Low
- AADI $1.21
- TTOO $0.31
- 52 Week High
- AADI $3.60
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- AADI 83.00
- TTOO 26.27
- Support Level
- AADI $2.25
- TTOO $0.33
- Resistance Level
- AADI $2.40
- TTOO $0.55
- Average True Range (ATR)
- AADI 0.22
- TTOO 0.05
- MACD
- AADI 0.05
- TTOO 0.01
- Stochastic Oscillator
- AADI 86.27
- TTOO 14.87
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.